← Leaderboards
Jianya Peng
Nemagen Discoveries, Inc
$307,094
Attributed
$307,094
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $252.1K · FY2022–23$500K$375K$250K$125K$0
'22
'23
Funding mix
By agency
NIH$307,094 · 1
By mechanism
R43$307,094 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “New Therapeutic Target”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Daniel Hunter Reirden · Westat, Inc.$16,121,731
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Channapatna S. Prakash · Tuskegee University$7,931,772
- Fumiaki Yokokawa · University Of Texas Med Br Galveston$7,180,989
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$7,024,010
Research focus
New Therapeutic TargetSmall Business Innovation Research GrantLeadMouse ModelPreventResponseEnzymesInhibitorMast CellMediatingNovel TherapeuticsOrganProgramsPublishingCarbonate DehydrataseEnzyme Inhibitor DrugsAbdominal PainFoundationsCarbonic Anhydrase InhibitorsLifeDesignMastocytosisAnaphylaxisStem Cells